Medivation’s Competitor Was Just Acquired, but It’s Not as Bad As It Sounds
Long Ideas - Shares of Medivation (MDVN) fell sharply on Monday June 17, closing down over 6% on news that Johnson & Johnson (JNJ) has acquired Aragon Pharmaceuticals … Continue Reading
Read now